Show simple item record

Erythrocyte CD38 as a prognostic marker in cancer.

dc.contributor.authorTuerker-Sener, Leyla
dc.contributor.authorBermek, Engin
dc.contributor.authorAlbeniz, Işıl
dc.contributor.authorYalçıntepe, Leman
dc.contributor.authorDemir, Ozlem
dc.contributor.authorNurten, Rüstem
dc.date.accessioned2021-03-03T11:59:55Z
dc.date.available2021-03-03T11:59:55Z
dc.date.issued2007
dc.identifier.citationAlbeniz I., Demir O., Tuerker-Sener L., Yalçıntepe L., Nurten R., Bermek E., "Erythrocyte CD38 as a prognostic marker in cancer.", Hematology (Amsterdam, Netherlands), cilt.12, sa.5, ss.409-14, 2007
dc.identifier.issn1024-5332
dc.identifier.otherav_2b43e9b0-5fea-4d0e-a7c3-aafb124792f9
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/33836
dc.identifier.urihttps://doi.org/10.1080/10245330701383841
dc.description.abstractBackground: Surface antigen CD38 which is a multifunctional protein with enzymatic and receptorial properties is involved in many processes of cell proliferation and activation. It is widely expressed within the hematopoetic system, and its expression is stimulated by proinflammatory cytokines. CD38-associated enzymatic activities in erythrocytes from cancer patients were investigated in this context.
dc.language.isoeng
dc.subjectHematoloji
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectHEMATOLOJİ
dc.titleErythrocyte CD38 as a prognostic marker in cancer.
dc.typeMakale
dc.relation.journalHematology (Amsterdam, Netherlands)
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume12
dc.identifier.issue5
dc.identifier.startpage409
dc.identifier.endpage14
dc.contributor.firstauthorID6903


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record